documents: FDA-2015-P-2820-0060
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-P-2820-0060 | FDA | FDA-2015-P-2820 | Exhibit 2 Baker et al How Regulatory Updates Allowing for More Modern Test Methods, Pragmatic Validation of Preclinical Test Methods, and FDA Guidances Will Lead to Advancement of More Predictive Preclinical Testing Tools, Efficiency, and Safer and More Effective Drugs FDLI Food and Drug Policy Forum re: Amendment from Center for Responsible Science | Supporting & Related Material | Background Material | 2016-03-18T04:00:00Z | 2016 | 3 | 2016-03-18T16:59:37Z | 0 | 0 | 0900006481ecf143 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref